Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical utility of plasma miR‐371a‐3p in germ cell tumors

7 Dec 2018

Abstract excerpt

Germ cell tumours predominantly of the testis ((T)GCTs) are remarkably chemotherapy sensitive. However, a small proportion of patients fail to be cured with cisplatin-based combination chemotherapy. miR-371a-3p is a new liquid biopsy biomarker for (T)GCTs. The aim of this study was to evaluate clinical utility of plasma miR-371a-3p level in patients starting systemic chemotherapy. Patients were included before...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromatin Remodeling and Cancer
Share to Sarcoma Diagnosis and Treatment
Share to Testicular diseases and treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30536846
DOI: 10.1111/jcmm.14013

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical utility of plasma miR‐371a‐3p in germ cell tumorsPMID 30536846Read ↗

Germ cell tumour subtypes display differential expression of microRNA371a-3pSemantic proximity Read ↗

A Multi-institutional Pooled Analysis Demonstrates That Circulating miR-371a-3p Alone is Sufficient for Testicular Malignant Germ Cell Tumor DiagnosisSemantic proximity Read ↗

The New Tumour Biomarker miRNA‐371‐3p Influences Cisplatin Sensitivity of Testicular Germ Cell Tumour Cell LinesSemantic proximity Read ↗

Serum Levels of MicroRNA miR-371a-3p: A Sensitive and Specific New Biomarker for Germ Cell TumoursSemantic proximity Read ↗

Serum Levels of MicroRNA-371a-3p for Predicting the Histology of Postchemotherapy Residual Masses of Germ Cell TumoursSemantic proximity Read ↗

Decoding testicular germ cell tumors: integrating risk, biology, and biomarkers into future care.Semantic proximity Read ↗

MicroRNA-371a-3p—The Novel Serum Biomarker in Testicular Germ Cell TumorsSemantic proximity Read ↗

MicroRNA-profiling of miR-371~373- and miR-302/367-clusters in Serum and Cerebrospinal Fluid Identify Patients with Intracranial Germ Cell TumorsSemantic proximity Read ↗

Current and Evolving Biomarkers in the Diagnosis and Management of Testicular Germ Cell TumorsSemantic proximity Read ↗

The Role of miRNA in Testicular Cancer: Current Insights and Future PerspectivesSemantic proximity Read ↗

Molecular biomarkers as potential targets for therapeutic strategies in human testicular germ cell tumors: An overviewSemantic proximity Read ↗

Serum Levels of MicroRNAs miR-371-3: A Novel Class of Serum Biomarkers for Testicular Germ Cell Tumors?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.